A biotech using AI to develop therapeutics that restore resilience and extend healthy human lifespan has appointed a Program Lead for Medicinal Chemistry.
The new appointment strengthens Gero’s in-house medicinal chemistry and structure-based design capabilities, enabling faster hit-to-lead progression and tighter integration between AI-driven insights and experimental validation.
By increasing the pace and control of pipeline development, this role supports Gero’s mission to rapidly advance new therapies aimed at extending healthy human life.
